Upcoming Hepatitis C Educational Webinar for Prescribers

Date: 02/09/24

Superior HealthPlan would like to inform providers that the Texas Health and Human Services Commission (HHSC) contracted with drug manufacturer AbbVie to improve awareness, screening, diagnosis, and treatment of the Hepatitis C Virus (HCV) for Medicaid members. HCV is a liver infection caused by a virus and often develops into a long-term or chronic illness. If untreated, HCV can cause significant damage to the body, such as liver cancer and cirrhosis.

In support of the HHSC initiative to improve awareness, screening, diagnosis, and treatment of HCV for Medicaid members, AbbVie will host an educational webinar for prescribers.

Webinar Details:

• Webinar Name: Treating Hepatitis C with Mavyret in your Practice
• Date: Wednesday, March 6, 2024
  • 12:15 p.m. CST or 11:15 a.m. MST
• Providers must register by Friday, March 1, 2024 by completing the Treating Hepatitis C with Mavyret in your Practice Registration Form

For additional information regarding the HCV webinar please visit the Vendor Drug Program (VDP) webpage.

For questions regarding this notice, please email vdp-operations@hhsc.state.tx.us.